Erschienen in:
27.09.2020 | COVID-19 | Letter to the Editor
Zur Zeit gratis
The role of neurotropism in psychiatric patients with COVID-19
verfasst von:
Ailyn D. Diaz, Raman Baweja
Erschienen in:
European Archives of Psychiatry and Clinical Neuroscience
|
Ausgabe 2/2021
Einloggen, um Zugang zu erhalten
Excerpt
Coronavirus 2019 (COVID-2019) has a significant negative psychological impact on psychiatric patients as compared to healthy controls with higher rates of posttraumatic stress disorder (31. 6%), moderate to severe anxiety (23%), depressive symptoms (22.4%), and suicidal ideations (11.8%) [
1]. Psychiatric patients are especially vulnerable for infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes the respiratory disease state known as COVID-19 [
2]. Medical comorbidities, such as diabetes mellitus and hypertension, magnify the risk of infection in the psychiatric population [
1,
2]. Factors such as impaired decision making, general psychomotor retardation, and poor adherence to social distancing can contribute to the susceptibility of infection [
2]. Moreover, psychiatric patients might not be aware of their personal space or be adherent to self-protection methods, such as handwashing or wearing masks. This poor adherence is especially dangerous due to the mode of transmission of SARS-CoV-2; it spreads mainly through respiratory inhalation of aerosolized droplets through human-to-human spread via asymptomatic incubation carriers [
3]. As the viral respiratory droplets are inhaled, it can spread to the lower respiratory tract causing dyspnea and, in some cases, attacking the central nervous system [
4,
5]. Due to the role of neurotropism of SARS-CoV-2, the psychiatric complications of COVID-19 and the associated immunoreactivity of the viral illness, should be evaluated by clinicians since exposed psychiatric patients can potentially display an exacerbation of psychosis and mood symptoms. …